Browse Category

BMV:AERO News 28 December 2025

Grupo Aeroméxico Stock (NYSE: AERO) Heads Into Monday on Strong Momentum: Latest Headlines, Analyst Targets, and Key Risks to Watch

Grupo Aeroméxico Stock (NYSE: AERO) Heads Into Monday on Strong Momentum: Latest Headlines, Analyst Targets, and Key Risks to Watch

NEW YORK, Dec. 27, 2025, 7:21 p.m. ET — Market closed Grupo Aeroméxico, S.A.B. de C.V. stock is heading into the next U.S. session with investors focused on two forces pulling the name in opposite directions: improving operating signals and bullish sell-side initiations on one side, and headline-driven regulatory risk around its U.S.–Mexico partnership framework on the other. With U.S. markets closed for the weekend, Aeroméxico’s NYSE-listed American Depositary Shares (ADS) last ended Friday’s session at $22.91, up about 3.3% on the day, according to market data compiled by StockAnalysis. StockAnalysis Weekend setup: where AERO stock stands now Aeroméxico (NYSE:
28 December 2025

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop